Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1 ‐antihistamine treatment: results of the phase IV open‐label SUNRISE study

British Journal of Dermatology, EarlyView.

Source: British Journal of Dermatology - September 17, 2018 Category: Dermatology Authors: F. B érard , M.C. Ferrier Le Bouedec , L. Bouillet , Z. Reguiai , A. Barbaud , F. Cambazard , B. Milpied , B. Pelvet , I. Kasujee , H. Gharbi , J.P. Lacour Source Type: research